Back to results
US 7,803,903 B2Granted
Protein-binding doxorubicin peptide derivatives
AssigneeKTB Tumorforschungs GmbH
InventorFelix Kratz
Life of this patent
Estimating the term…
Abstract
The invention relates to low-molecular doxorubicin peptide derivatives containing MMP-2 or MMP-9 divisible peptide sequences and a protein-binding group.
Claims22
A doxorubicin-peptide of the formula I
- wherein
- Y=O or S
- n=1 to 5
- m=0 to 6
- P5-P′5 denotes a peptide sequence consisting of up to ten amino acids, said amino acids being selected from the group consisting of the twenty essential amino acids,
- wherein the peptide sequence can be cleaved by the matrix metalloproteinase 2 and/or 9 (MMP-2 and/or MMP-9) and
- PM is a protein-binding group which is a maleinimide group, a 2-dithiopyridyl group, a halogen acetamide group, a halogen acetate group, a disulfide group, an acrylic acid ester group, a monoalkylmaleic acid ester group, a monoalkylmaleaminic acid amide group, an isothiocyanate group or an aziridine group, which is optionally substituted and
4 more elements
Dependencies are inferred from the claim text.